Biotech News
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
ir.fulgentgenetics.com2026-05-06 15:27 EST
EL MONTE, Calif. --(BUSINESS WIRE)--Feb. 12, 2026-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its fourth quarter and